|
|
|
|
Science Sparks @ ACTREC
|
 27th May 2024 |
Vol. No. 13 ; Issue No.631 |
|
|
Publications
|
|
1. Dalal N, Dandia H, Ingle A, Tayalia P (2024). Surface-modified injectable poly(ethylene-glycol) diacrylate-based cryogels for localized gene delivery. Biomedical Physics & Engineering Express.
2. Koli S, Shetty S (2024). Ribosomal dormancy at the nexus of ribosome homeostasis and protein synthesis. Bioessays.
3. Multani K, Velayutham P, Moiyadi A (2024). Utility Of multimodal Intraoperative Neuromonitoring (IONM) For excision of filum terminale ependymoma in close proximity to conus. World Neurosurgery.
4. Patil B, Chavan N, Gota V, Bhaskar V, Kulkarni P. Development and validation of a bioanalytical technique entitled 5-fluorouracil (5FU) used in therapeutic drug monitoring. Research Journal of Pharmacy and Technology. 17(5): 2345-51.
5. Anjikar A, Iwasaki K, Paneerselvam R, Hole A, CM Krishna, Noothalapati H, Dutt S, Yamamoto T (2024). Discernable machine learning methods for Raman micro-spectroscopic stratification of mitoxantrone-induced drug-resistant cells in acute myeloid leukemia. Journal of Raman Spectroscopy.
|
|
|
|
|
Interesting Reads
|
|
Morsy MHA, Lilienthal I, Lord M, Merrien M, Wasik AM, Sureda-Gómez M, Amador V, Johansson HJ, Lehtiö J, Garcia-Torre B, Martin-Subero JI, Tsesmetzis N, Tao S, Schinazi RF, Kim B, Sorteberg AL, Wickström M, Sheppard D, Rassidakis GZ, Taylor IA, Christensson B, Campo E, Herold N, Sander B. SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma. Blood. 143(19):1953-1964, 2024.
|
|
|
Video of the Week
|
|
| Innovation and Research@ Tata Memorial Centre: Practical Solutions for Affordable Cancer Care in India. |
|
| |
|
|
| |
|
|
|
|
Do You Know?
In 1996, FDA approved anastrozole (Arimidex) as a treatment for breast cancer. This drug blocks the production of estrogen.
|
|
|
|
Cancer News
|
| |
|
|
| |
|
|
|
Pembrolizumab provides first ever overall survival improvement in kidney cancer.
|
|
National Cancer Institute, 21/05/2024
|
|
The immunotherapy drug pembrolizumab (Keytruda) has rapidly become one of the most widely used cancer treatments. Based on updated results from a large clinical trial, the drug is now part of an important milestone in the treatment of kidney cancer specifically, clear-cell renal cell carcinoma, the most common form of the disease
...
|
|
|
|
|
|
|
|
|
2019 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|
